Express Scripts Holding Revenue 2006-2018 | ESRX

Express Scripts Holding annual/quarterly revenue history and growth rate from 2006 to 2018. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Express Scripts Holding revenue for the quarter ending September 30, 2018 was $25.563B, a 3.56% increase year-over-year.
  • Express Scripts Holding revenue for the twelve months ending September 30, 2018 was $101.353B, a 1.81% increase year-over-year.
  • Express Scripts Holding annual revenue for 2017 was $100.065B, a 0.22% decline from 2016.
  • Express Scripts Holding annual revenue for 2016 was $100.288B, a 1.44% decline from 2015.
  • Express Scripts Holding annual revenue for 2015 was $101.752B, a 0.86% increase from 2014.
Express Scripts Holding Annual Revenue
(Millions of US $)
2017 $100,065
2016 $100,288
2015 $101,752
2014 $100,887
2013 $104,099
2012 $93,714
2011 $46,128
2010 $44,973
2009 $24,722
2008 $21,941
2007 $21,824
2006 $21,563
2005 $16,188
Express Scripts Holding Quarterly Revenue
(Millions of US $)
Q3 2018 $25,563
Q2 2018 $25,642
Q1 2018 $24,769
Q4 2017 $25,379
Q3 2017 $24,683
Q2 2017 $25,348
Q1 2017 $24,655
Q4 2016 $24,863
Q3 2016 $25,410
Q2 2016 $25,222
Q1 2016 $24,792
Q4 2015 $26,175
Q3 2015 $25,223
Q2 2015 $25,454
Q1 2015 $24,900
Q4 2014 $26,313
Q3 2014 $25,779
Q2 2014 $25,111
Q1 2014 $23,685
Q4 2013 $25,781
Q3 2013 $25,916
Q2 2013 $26,382
Q1 2013 $26,020
Q4 2012 $27,315
Q3 2012 $26,762
Q2 2012 $27,505
Q1 2012 $12,133
Q4 2011 $12,101
Q3 2011 $11,571
Q2 2011 $11,361
Q1 2011 $11,095
Q4 2010 $11,294
Q3 2010 $11,252
Q2 2010 $11,289
Q1 2010 $11,138
Q4 2009 $8,190
Q3 2009 $5,613
Q2 2009 $5,497
Q1 2009 $5,423
Q4 2008 $5,469
Q3 2008 $5,451
Q2 2008 $5,531
Q1 2008 $5,491
Q4 2007 $7,382
Q3 2007 $5,358
Q2 2007 $4,575
Q1 2007 $4,509
Q4 2006 $8,431
Q3 2006 $4,330
Q2 2006 $4,421
Q1 2006 $4,380
Q4 2005 $4,557
Q3 2005 $3,848
Q2 2005 $3,944
Q1 2005 $3,839
Sector Industry Market Cap Revenue
Medical Medical Services $54.401B $100.065B
Express Scripts Holding Company puts medicine within reach of tens of millions of people by aligning with plan sponsors, taking bold action and delivering patient-centered care to make better health more affordable and accessible. Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management, and medical and drug data analysis services. Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.
Stock Name Country Market Cap PE Ratio
ICON (ICLR) Ireland $7.342B 23.01
PRA Health Sciences (PRAH) United States $6.613B 27.00
Charles River Laboratories (CRL) United States $6.190B 21.70
Premier (PINC) United States $5.294B 18.04
HealthEquity (HQY) United States $5.236B 109.60
INC Research Holdings (SYNH) United States $5.099B 20.58
Teladoc (TDOC) United States $4.024B 0.00
NovoCure (NVCR) Jersey $2.835B 0.00
AMN Healthcare Services Inc (AMN) United States $2.676B 18.36
BioTelemetry (BEAT) United States $1.998B 35.29
Medpace Holdings (MEDP) United States $1.982B 24.53
Healthways (TVTY) United States $1.499B 18.44
Intrexon (XON) United States $1.343B 0.00
IKang Healthcare (KANG) China $1.129B 56.07
CareDx (CDNA) United States $1.027B 0.00
Natera (NTRA) United States $0.953B 0.00
China Cord Blood (CO) China $0.802B 21.29
Surgery Partners (SGRY) United States $0.665B 0.00
Apollo Medical Holdings (AMEH) United States $0.629B 0.00
Establishment Labs Holdings (ESTA) $0.566B 0.00
Civitas Solutions (CIVI) United States $0.520B 10.24
OncoCyte (OCX) United States $0.069B 0.00
Interpace Diagnostics (IDXG) United States $0.033B 0.00
Cancer Genetics (CGIX) United States $0.015B 0.00
OpGen (OPGN) United States $0.008B 0.00
FORM Holdings (XSPA) United States $0.005B 0.00
Biocept (BIOC) United States $0.004B 0.00